For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 33,601 | |||
| Sales and marketing | 2,171 | |||
| General and administrative | 15,196 | |||
| Gain on lease modification, net | 941 | |||
| Total operating expenses | 50,027 | |||
| Loss from operations | -50,027 | |||
| Loss on disposal of leasehold improvements | -1,915 | |||
| Change in fair value of warrant liabilities | -787 | |||
| Interest and other income, net | 973 | |||
| Total other (expense) income, net | -155 | |||
| Net loss | -50,182 | |||
| Net unrealized (loss) income on investments | -46 | |||
| Other comprehensive (loss) income | -46 | |||
| Comprehensive net loss | -50,228 | |||
| Basic EPS | -8.19 | |||
| Diluted EPS | -8.19 | |||
| Basic Average Shares | 6,130,652 | |||
| Diluted Average Shares | 6,130,652 | |||
Vicarious Surgical Inc. (RBOTW)
Vicarious Surgical Inc. (RBOTW)